  Lung cancer is the leading cause of the largest number of deaths worldwide
and lung adenocarcinoma (LUAD) is the most common form of lung cancer. In this
study, we carried out an integrated meta-analysis of the mutations including
single-nucleotide variations (SNVs), the copy number variations (CNVs), RNA-seq
and clinical data of patients with LUAD downloaded from The Cancer Genome Atlas
(TCGA). We integrated significant SNV and CNV genes, differentially expressed
genes (DEGs) and the DEGs in active subnetworks to construct a prognosis
signature. Cox proportional hazards model (LOOCV) with Lasso penalty was used
to identify the best gene signature among different gene categories. The
patients in both training and test data were clustered into high-risk and
low-risk groups by using risk scores of the patients calculated based on
selected gene signature. We generated a 12-gene signature (DEPTOR, ZBTB16,
BCHE, MGLL, MASP2, TNNI2, RAPGEF3, SGK2, MYO1A, CYP24A1, PODXL2, CCNA1) for
overall survival prediction. The survival time of high-risk and low-risk groups
was significantly different. This 12-gene signature could predict prognosis and
they are potential predictors for the survival of the patients with LUAD.
